Crimean-Congo Hemorrhagic Fever Virus Monoclonal Antibodies: A Work In Progress

A recent study on Crimean-Congo Hemorrhagic Fever Virus may pave the way for a new monoclonal antibody treatment in the near future.

Read the full post on Forbes - Healthcare

William A. Haseltine, Contributor